Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

Dow Jones

Mar 04, 2025

DJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ advanced 1.60% to $140.22 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.76% to 5,849.72 and Dow Jones Industrial Average falling 1.48% to 43,191.24.

This was the stock's second consecutive day of gains.

Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $138.37, which the company achieved on February 28th.

The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.37% to $167.28, Pfizer Inc. $(PFE)$ fell 0.68% to $26.25, and Merck & Co. Inc. $(MRK)$ rose 0.98% to $93.15.

Trading volume (7.6 M) eclipsed its 50-day average volume of 6.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 03, 2025 16:33 ET (21:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2516669704"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2516669704\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2516669704?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 05:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516669704","market":"fut","top_or_hot":-1,"title":"Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Abbott Laboratories <a href=\"https://laohu8.com/S/ABT\">$(ABT)$</a> advanced 1.60% to $140.22 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index  falling 1.76% to 5,849.72 and Dow Jones Industrial Average  falling 1.48% to 43,191.24. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $138.37, which the company achieved on February 28th. \n</p>\n<p>\n     The stock outperformed some of its competitors Monday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 1.37% to $167.28, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.68% to $26.25, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> rose 0.98% to $93.15. \n</p>\n<p>\n     Trading volume (7.6 M) eclipsed its 50-day average volume of 6.2 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2025 16:33 ET (21:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbbott Laboratories Stock Outperforms Competitors On Strong Trading Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-04 05:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Abbott Laboratories <a href=\"https://laohu8.com/S/ABT\">$(ABT)$</a> advanced 1.60% to $140.22 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index  falling 1.76% to 5,849.72 and Dow Jones Industrial Average  falling 1.48% to 43,191.24. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $138.37, which the company achieved on February 28th. \n</p>\n<p>\n     The stock outperformed some of its competitors Monday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 1.37% to $167.28, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.68% to $26.25, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> rose 0.98% to $93.15. \n</p>\n<p>\n     Trading volume (7.6 M) eclipsed its 50-day average volume of 6.2 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2025 16:33 ET (21:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABT","symbol_name":"雅培","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2516669704","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516669704","pubTimestamp":1741037580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  advanced 1.60% to $140.22 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.76% to 5,849.72 and Dow Jones Industrial Average  falling 1.48% to 43,191.24.This was the stock's second consecutive day of gains.Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $138.37, which the company achieved on February 28th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 1.37% to $167.28, Pfizer Inc.  fell 0.68% to $26.25, and Merck & Co. Inc.  rose 0.98% to $93.15.Trading volume  eclipsed its 50-day average volume of 6.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"ABT":"雅培"},"translate_title":"雅培实验室股票在强劲交易日表现优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1},"content_text":"DJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Abbott Laboratories $(ABT)$ advanced 1.60% to $140.22 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.76% to 5,849.72 and Dow Jones Industrial Average  falling 1.48% to 43,191.24. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $138.37, which the company achieved on February 28th. \n\n\n     The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.37% to $167.28, Pfizer Inc. $(PFE)$ fell 0.68% to $26.25, and Merck & Co. Inc. $(MRK)$ rose 0.98% to $93.15. \n\n\n     Trading volume (7.6 M) eclipsed its 50-day average volume of 6.2 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 16:33 ET (21:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}